We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $150M invested in VanEck Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

0% more funds holding

Funds holding: 115 → 115 (0)

1% less capital invested

Capital invested by funds: $152M → $150M (-$1.49M)

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

40.53% less ownership

Funds ownership: 78.34% → 37.81% (-41%)

Holders
115
Holders Change
–
Holders Change %
0%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
32
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TWC
TD Waterhouse Canada
Ontario, Canada
+$10.7M
2
Bank of America
Bank of America
North Carolina
+$6.74M
3
Morgan Stanley
Morgan Stanley
New York
+$3.25M
4
ACA
Atlas Capital Advisors
Wyoming
+$959K
5
TAM
Tocqueville Asset Management
New York
+$922K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.7M
2
GT
Glenview Trust
Kentucky
-$1.65M
3
Jane Street
Jane Street
New York
-$1.48M
4
MIM
Miller Investment Management
Pennsylvania
-$1.28M
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$19.2M -$229K -1,362 -1%
MIM
2
Miller Investment Management
Pennsylvania
$14.5M -$1.28M -7,614 -8%
Morgan Stanley
3
Morgan Stanley
New York
$14.4M +$3.25M +19,327 +27%
Bank of America
4
Bank of America
North Carolina
$13.6M +$6.74M +40,052 +86%
Wells Fargo
5
Wells Fargo
California
$11.9M +$684K +4,064 +6%
TWC
6
TD Waterhouse Canada
Ontario, Canada
$9.97M +$10.7M +63,556 New
Commonwealth Equity Services
7
Commonwealth Equity Services
Massachusetts
$4.78M -$56.9K -338 -1%
UBS Group
8
UBS Group
Switzerland
$4.37M +$126K +751 +3%
LPL Financial
9
LPL Financial
California
$3.88M -$257K -1,527 -6%
Raymond James Financial
10
Raymond James Financial
Florida
$3.38M +$3.62M +21,539 New
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$3.24M -$662K -3,934 -16%
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$2.94M -$631K -3,751 -17%
CCA
13
Conservest Capital Advisors
Pennsylvania
$2.78M -$92.2K -548 -3%
CIG
14
Consolidated Investment Group
Colorado
$2.54M – – –
PAW
15
Plan A Wealth
Nebraska
$2.37M +$2.54M +15,100 New
BRM
16
Boston Research & Management
Massachusetts
$1.83M – – –
Rockefeller Capital Management
17
Rockefeller Capital Management
New York
$1.81M – – –
JP Morgan Chase
18
JP Morgan Chase
New York
$1.61M -$305K -1,811 -15%
AGC
19
Aspen Grove Capital
Colorado
$1.57M +$13.1K +78 +0.8%
HighTower Advisors
20
HighTower Advisors
Illinois
$1.55M +$178K +1,058 +12%
PGFC
21
Peapack-Gladstone Financial Corp
New Jersey
$1.49M -$185K -1,100 -10%
Corient Private Wealth
22
Corient Private Wealth
Florida
$1.36M – – –
Ameriprise
23
Ameriprise
Minnesota
$1.25M +$628K +3,733 +89%
IFWM
24
Institute for Wealth Management
Colorado
$1.19M +$336 +2 +0%
Stifel Financial
25
Stifel Financial
Missouri
$1.06M -$1.01K -6 -0.1%
1
2 3 4 5

BBH Hedge Fund Activity: Q4 2024 in Review

115 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2024, worth a combined $150M — down 0.98% from $152M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 13 closed out — a net gain of 3 holders — while 24 added to existing stakes and 32 trimmed.

The largest buyer was TD Waterhouse Canada, opening a new position worth an estimated $10.7M. The largest seller was Citadel Advisors, cutting an estimated $2.7M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $150M of VanEck Biotech ETF stock for Q4 2024, down 0.98% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q4 2024 and 13 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2024 was TD Waterhouse Canada, an estimated $10.7M added.
  • The largest VanEck Biotech ETF seller in Q4 2024 was Citadel Advisors, an estimated $2.7M sold.

Based on aggregated 13F filings for Q4 2024.